1. Esomeprazole
2. Esomeprazole Magnesium
3. Esomeprazole Potassium
4. Esomeprazole Sodium
5. Esomeprazole Strontium
6. Esomeprazole Strontium Anhydrous
7. Nexium
8. Strontium, Esomeprazole
1. Esomeprazole Sodium
2. Esomeprazole (sodium)
3. H199/18 Sodium
4. Esomeprazole (as Sodium)
5. Esomeprazole Sodium [usan]
6. 161796-78-7
7. Esomeprazole Sodium (usan)
8. (s)-omeprazole Sodium Salt
9. L2c9gwq43h
10. Sodium;5-methoxy-2-[(s)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide
11. Nexium Iv (tn)
12. 1h-benzimidazole, 5-methoxy-2-((s)-((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-, Sodium Salt
13. 5-methoxy-2-((s)-((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)-1h-benzimidazole, Sodium Salt
14. Chembl1200470
15. Esomeprazole Sodium [vandf]
16. Esomeprazole Sodium [mart.]
17. Esomeprazole Sodium [who-dd]
18. S2233
19. Ccg-268253
20. Esomeprazole Sodium [orange Book]
21. Esomeprazole Sodium [ep Monograph]
22. Hy-17023
23. O0560
24. 1h-benzimidazole, 6-methoxy-2-((s)-((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-, Sodium Salt (1:1)
25. D04056
26. Q-100194
27. Q27282619
28. 5-methoxy-2-[(s)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1h-benzimidazole Sodium Salt
| Molecular Weight | 367.4 g/mol |
|---|---|
| Molecular Formula | C17H18N3NaO3S |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 5 |
| Exact Mass | 367.09665690 g/mol |
| Monoisotopic Mass | 367.09665690 g/mol |
| Topological Polar Surface Area | 81.5 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 459 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Esomeprazole sodium |
| Drug Label | The active ingredient in esomeprazole sodium for injection is (S)-5-methoxy-2[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1 H-benzimidazole sodium, a proton pump inhibitor that inhibits gastric acid secretion. Esomeprazole is the S-isome... |
| Active Ingredient | Esomeprazole sodium |
| Dosage Form | Injectable |
| Route | Intravenous |
| Strength | eq 20mg base/vial; eq 40mg base/vial |
| Market Status | Prescription |
| Company | Sun Pharma Global |
| 2 of 2 | |
|---|---|
| Drug Name | Esomeprazole sodium |
| Drug Label | The active ingredient in esomeprazole sodium for injection is (S)-5-methoxy-2[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1 H-benzimidazole sodium, a proton pump inhibitor that inhibits gastric acid secretion. Esomeprazole is the S-isome... |
| Active Ingredient | Esomeprazole sodium |
| Dosage Form | Injectable |
| Route | Intravenous |
| Strength | eq 20mg base/vial; eq 40mg base/vial |
| Market Status | Prescription |
| Company | Sun Pharma Global |
Anti-Ulcer Agents
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)
Proton Pump Inhibitors
Compounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX. (See all compounds classified as Proton Pump Inhibitors.)
